Origin and evolution of the unique hepatitis C virus circulating recombinant form 2k/1b

Journal of Virology

Volumn 86, Issue 4, 2012, Pages 2212-2220

  Raghwani, Jayna ^a   Thomas, Xiomara V ^b   Koekkoek, Sylvie M ^b   Schinkel, Janke ^b   Molenkamp, Richard ^b   van de Laar, Thijs J ^c   Takebe, Yutaka ^d   Tanaka, Yasuhito ^e   Mizokami, Masashi ^f   Rambaut, Andrew ^a,g   Pybus, Oliver G ^h  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^e NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^f NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^g NATIONAL INSTITUTES OF HEALTH   (United States)

^h UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BAYES THEOREM; CONTROLLED STUDY; DNA FLANKING REGION; HEPATITIS C VIRUS; MOLECULAR CLOCK; MOLECULAR PHYLOGENY; NETHERLANDS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; USSR; VIRUS GENOME; VIRUS RECOMBINATION; VIRUS STRAIN; VIRUS TRANSMISSION;

ADULT; EVOLUTION, MOLECULAR; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NETHERLANDS; PHYLOGENY; RECOMBINATION, GENETIC; RUSSIA; YOUNG ADULT;

HEPATITIS C VIRUS;

EID: 84863421649     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06184-11     Document Type: Article

References (72)

1. Aitken CK, et al. 2008. High incidence of hepatitis C virus reinfection in a cohort of injecting drug users. Hepatology 48:1746-1752.
2. Appel N, Herian U, Bartenschlager R. 2005. Efficient rescue of hepatitis C virus RNA replication by trans-complementation with nonstructural protein 5A. J. Virol. 79:896-909.
3. Blackard JT, Sherman KE. 2007. Hepatitis C virus coinfection and superinfection. J. Infect. Dis. 195:519-524.
4. Boom R, et al. 1990. Rapid and simple method for purification of nucleicacids. J. Clin. Microbiol. 28:495-503.
5. Bowden S, McCaw R, White PA, Crofts N, Aitken CK. 2005. Detection of multiple hepatitis C virus genotypes in a cohort of injecting drug users. J. Viral Hepat. 12:322-324.
6. Calado RA, et al. 2011. Hepatitis C virus subtypes circulating among intravenous drug users in Lisbon, Portugal. J. Med. Virol. 83:608-615.
7. Colina R, et al. 2004. Evidence of intratypic recombination in natural populations of hepatitis C virus. J. Gen. Virol. 85:31-37.
8. Cristina J, Colina R. 2006. Evidence of structural genomic region recombination in hepatitis C virus. Virology J. 3:53.
9. Demetriou VL, de Vijver DAMCV, Kostrikis LG, Network CHCV. 2009. Molecular epidemiology of hepatitisCinfection in Cyprus: evidence of polyphyletic infection. J. Med. Virol. 81:238-248.
10. Drummond AJ, Ho SYW, Phillips MJ, Rambaut A. 2006. Relaxed phylogenetics and dating with confidence. PLoS Biol. 4:699-710.
11. Drummond AJ, Rambaut A. 2007. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol. Biol. 7:214.
12. Drummond AJ, Rambaut A, Shapiro B, Pybus OG. 2005. Bayesian coalescent inference of past population dynamics from molecular sequences. Mol. Biol. Evol. 22:1185-1192.
13. Dubois F, et al. 1997. Hepatitis C in a French population-based survey, 1994: seroprevalence, frequency of viremia, genotype distribution, and risk factors. Hepatology 25:1490-1496.
14. Gray RR, et al. 2011. The mode and tempo of hepatitis C virus evolution within and among hosts. BMC Evol. Biol. 11:131.
15. Herlihy KJ, et al. 2008. Development of intergenotypic chimeric replicons to determine the broad-spectrum antiviral activities of hepatitis C virus polymerase inhibitors. Antimicrob. Agents Chemother. 52:3523-3531.
16. Herring BL, Page-Shafer K, Tobler LH, Delwart EL. 2004. Frequent hepatitis C virus superinfection in injection drug users. J. Infect. Dis. 190:1396-1403.
17. Hu WS, Temin HM. 1990. Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination. Proc. Natl. Acad. Sci. U. S. A. 87:1556-1560.
18. Huestis DW. 2002. Russia's National Research Center for Hematology: its role in the development of blood banking. Transfusion 42:490-494.
19. Kageyama S, et al. 2006. A natural inter-genotypic (2b/1b) recombinant of hepatitis C virus in the Philippines. J. Med. Virol. 78:1423-1428.
20. Kalinina O, Norder H, Mukomolov S, Magnius LO. 2002. A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg. J. Virol. 76:4034-4043.
21. Kalinina O, et al. 2001. Shift in predominating subtype of HCV from 1b to 3a in St. Petersburg mediated by increase in injecting drug use. J. Med. Virol. 65:517-524.
22. Kapoor A, et al. 2011. Characterization of a canine homolog of hepatitis C virus. Proc. Natl. Acad. Sci. U. S. A. 108:11608-11613.
23. Kuiken C, Simmonds P. 2009. Nomenclature and numbering of the hepatitis C virus. Methods Mol. Biol. 510:33-53.
24. Kuiken C, Yusim K, Boykin L, Richardson R. 2005. The Los Alamos hepatitis C sequence database. Bioinformatics 21:379-384.
25. Kurbanov F, et al. 2008. Detection of hepatitis C virus natural recombinant RF1_2k/1b strain among intravenous drug users in Uzbekistan. Hepatol. Res. 38:457-464.
26. Kurbanov F, et al. 2008. Molecular epidemiology and interferon susceptibility of the natural recombinant hepatitis C virus strain RF1_2k/1b. J. Infect. Dis. 198:1448-1456.
27. Lam TY, et al. 2008. Evolutionary analyses of European H1N2 swine influenza A virus by placing timestamps on the multiple reassortment events. Virus Res. 131:271-278.
28. Lee YM, et al. 2010. Molecular epidemiology of HCV genotypes among injection drug users in Taiwan: full-length sequences of two new subtype 6w strains and a recombinant form_2b6w. J. Med. Virol. 82:57-68.
29. Legrand-Abravanel F, et al. 2007. New natural intergenotypic (2/5) recombinant of hepatitis C virus. J. Virol. 81:4357-4362.
30. Leitner T, Korber B, Daniels M, Calef C, Foley B. 2005. HIV-1 subtype and circulating recombinant form (CRF) reference sequences, 2005, p 41-48. In Leitner T, et al (ed), HIV sequence compendium 2005. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM.
31. Lemon SM, Brown EA. 1995. Hepatitis C virus, p 1474-1486. In Mandel GL, Bennett JE, Dolin R (ed), Principle and practice of infectious disease, 4th ed. Churchill Livingstone, New York, NY.
32. Li Y, et al. 2010. Identification of a novel second-generation circulating recombinant form (CRF48_01B) in Malaysia: a descendant of the previously identified CRF33_01B. J. Acquir. Immune Defic. Syndr. 54:129-136.
33. Magiorkinis G, et al. 2009. The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis. PLoS Med. 6:e1000198.
34. Markov PV, et al. 2009. Phylogeography and molecular epidemiology of hepatitis C virus genotype 2 in Africa. J. Gen. Virol. 90:2086-2096.
35. Matusevich M. 2009. Black in the U.S.S.R.: Africans, African Americans, and the Soviet society. Transition 100:56-75.
36. Minin VN, Bloomquist EW, Suchard MA. 2008. Smooth skyride through a rough skyline: Bayesian coalescent-based inference of population dynamics. Mol. Biol. Evol. 25:1459-1471.
37. Moreau I, et al. 2006. Serendipitous identification of natural intergenotypic recombinants of hepatitis C in Ireland. Virol. J. 3:95-102.
38. Morel V, et al. 2010. Emergence of a genomic variant of the recombinant 2k/1b strain during a mixed hepatitis C infection: a case report. J. Clin. Virol. 47:382-386.
39. Moreno P, et al. 2009. Evidence of recombination in hepatitis C virus populations infecting a hemophiliac patient. Virol. J. 6:203.
40. Murphy DG, et al. 2007. Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C/E1 and 5′ untranslated region sequences. J. Clin. Microbiol. 45:1102-1112.
41. Newton MA, Raftery AE. 1994. Approximate Bayesian-inference with the weighted likelihood bootstrap. J. R. Stat. Soc. Ser. B Methodol. 56:3-48.
42. Noppornpanth S, et al. 2006. Identification of a naturally occurring recombinant genotype 2/6 hepatitis C virus. J. Virol. 80:7569-7577.
43. Osburn WO, et al. 2010. Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection. Gastroenterology 138:315-324.
44. Pawlotsky JM, et al. 1995. Relationship between hepatitis-C virus genotypes and sources of infection in patients with chronic hepatitis-C. J. Infect. Dis. 171:1607-1610.
45. Pol S, et al. 1995. The changing relative prevalence of hepatitis-C virus genotypes-evidence in hemodialyzed patients and kidney recipients. Gastroenterology 108:581-583.
46. Pybus OG, et al. 2001. The epidemic behavior of the hepatitis C virus. Science 292:2323-2325.
47. Pybus OG, Cochrane A, Holmes EC, Simmonds P. 2005. The hepatitis C virus epidemic among injecting drug users. Infect. Genet. Evol. 5:131-139.
48. Pybus OG, Drummond AJ, Nakano T, Robertson BH, Rambaut A. 2003. The epidemiology and iatrogenic transmission of hepatitisCvirus in Egypt: a Bayesian coalescent approach. Mol. Biol. Evol. 20:381-387.
49. Pybus OG, Markov PV, Wu A, Tatem AJ. 2007. Investigating the endemic transmission of the hepatitis C virus. Int. J. Parasitol. 37:839-849.
50. Qian KP, Natov SN, Pereira BJ, Lau JY. 2000. Hepatitis C virus mixed genotype infection in patients on haemodialysis. J. Viral Hepat. 7:153-160.
51. Ristic N, et al. 2011. Analysis of the origin and evolutionary history of HIV-1 CRF28_BF and CRF29_BF reveals a decreasing prevalence in the AIDS epidemic of Brazil. PLoS One 6:e17485.
52. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. 1996. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N. Engl. J. Med. 334:1685-1690.
53. Schroter M, Feucht HH, Zollner B, Schafer P, Laufs R. 2003. Multiple infections with different HCV genotypes: prevalence and clinical impact. J. Clin. Virol. 27:200-204.
54. Seeff LB, et al. 2000. 45-year follow-up of hepatitis C virus infection in healthy young adults. Ann. Intern. Med. 132:105-111.
55. Shapiro B, Rambaut A, Drummond AJ. 2006. Choosing appropriate substitution models for the phylogenetic analysis of protein-coding sequences. Mol. Biol. Evol. 23:7-9.
56. Shepard CW, Finelli L, Alter MJ. 2005. Global epidemiology of hepatitis C virus infection. Lancet Infect. Dis. 5:558-567.
57. Silini E, et al. 1995. Molecular epidemiology of hepatitis-C virus-infection among intravenous-drug-users. J. Hepatol. 22:691-695.
58. Simmonds P. 2004. Genetic diversity and evolution of hepatitis C virus- 15 years on. J. Gen. Virol. 85:3173-3188.
59. Simmonds P, Smith DB. 1999. Structural constraints on RNA virus evolution. J. Virol. 73:5787-5794.
60. Smith DB, et al. 1997. The origin of hepatitis C virus genotypes. J. Gen. Virol. 78(Pt 2):321-328.
61. Starr D. 1999. Blood: an epic history of medicine and commerce. Little, Brown & Company, London, United Kingdom.
62. Suchard MA, Kitchen CMR, Sinsheimer JS, Weiss RE. 2003. Hierarchical phylogenetic models for analyzing multipartite sequence data. Syst. Biol. 52:649-664.
63. Suchard MA, Weiss RE, Sinsheimer JS. 2001. Bayesian selection of continuoustime Markov chain evolutionary models. Mol. Biol. Evol. 18:1001-1013.
64. Swofford D. 2003. PAUP*. Phylogenetic analysis using parsimony (*and other methods), version 4. Sinauer Associates, Sunderland, MA.
65. Tanaka Y, et al. 2004. Exponential spread of hepatitis C virus genotype 4a in Egypt. J. Mol. Evol. 58:191-195.
66. Tanaka Y, et al. 2005. Molecular evolutionary analyses implicate injection treatment for schistosomiasis in the initial hepatitis C epidemics in Japan. J. Hepatol. 42:47-53.
67. Tee KK, et al. 2009. Estimating the date of origin of an HIV-1 circulating recombinant form. Virology 387:229-234.
68. Tuplin A, Wood J, Evans DJ, Patel AH, Simmonds P. 2002. Thermodynamic and phylogenetic prediction of RNA secondary structures in the coding region of hepatitis C virus. RNA 8:824-841.
69. van de Laar TJ, et al. 2009. Frequent HCV reinfection and superinfection in a cohort of injecting drug users in Amsterdam. J. Hepatol. 51:667-674.
70. van der Poel CL. 1999. Hepatitis C virus and blood transfusion: past and present risks. J. Hepatology 31(Suppl 1):101-106.
71. WHO. 2003, posting date. Global alert and response (GAR): hepatitis C. WHO, Geneva, Switzerland.
72. Worobey M, Holmes EC. 1999. Evolutionary aspects of recombination in RNA viruses. J. Gen. Virol. 80:2535-2543.